Efficiency analysis of competing tests for finding differentially expressed genes in lung adenocarcinoma

Cancer Informatics

Volumn 6, Issue , 2008, Pages 389-421

  Jordan, Rick ^a,b   Patel, Satish ^c   Hu, Hai ^d   Lyons Weiler, James ^a,b,e  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d WINDBER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; CANCER EPIDEMIOLOGY; CONTROLLED STUDY; GENE EXPRESSION; GENETIC DIFFERENCE; HUMAN; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; SENSITIVITY AND SPECIFICITY; TUMOR GENE; ANALYTIC METHOD; ANALYTICAL ERROR; BAYES THEOREM; EFFICIENCY ANALYSIS; EXTERNAL CONSISTENCY; GENE IDENTIFICATION; GENETIC DATABASE; INFORMATION PROCESSING; INTERNAL CONSISTENCY; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; RELIABILITY; VALIDATION STUDY;

EID: 49949103770     PISSN: 11769351     EISSN: 11769351     Source Type: Journal    
DOI: 10.4137/cin.s791     Document Type: Article

References (42)

1. Somiari, S.B. et al. 2004. Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization. Cancer Genetics and Cytogenetics, 155:108-11.
2. Hanahan, D. et al. 2000. The hallmarks of cancer. Cell., 100:57-70.
3. Ellsworth, R.E. et al. 2003. High-throughput loss of heterozygosity mapping in 26 commonly deleted regions in breast cancer. Cancer Epidemiology, Biomarkers and Prevention, 12:915-9.
4. Wulfkuhle, J.D. et al. 2003. Proteomic applications for the early detection of cancer. Nature Reviews Cancer, 3:267-75.
5. Somiari, R.I. et al. 2003. High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast. Proteomics., 3:1863-73.
6. Arciero, C. et al. 2003. Functional relationship and gene ontology classification of breast cancer biomarkers. The International Journal of Biological Markers, 18:241-72.
7. Greenlee, R.T. et al. 2001. Cancer Statistics 2001. CA Cancer Journal of Clinicians, 51:15-36.
8. Fry, W.A. et al. 1999. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer database report. Cancer, 86:1867-76.
9. Beer, D.G. et al. 2002. Gene expression profiles predict survival of patients with lung adenocarcinoma. Nature Medicine, 8(8):816-24.
10. Sorensen, J.B. et al. 1993. Interobserver variability in histopathologic subtyping and grading of pulmonary adenocarcinoma. Cancer, 71:2971-6.
11. Shirakusa, T. et al. 1988. Resection of metastatic lung tumor: the evaluation of histologic appearance in the lung. American Surgeon, 54:655-8.
12. Flint, A. et al. 1992. Pulmonary metastases of colonic carcinoma. Distinction from pulmonary adenocarcinoma. Archives of Pathology Laboratory Medicine, 116:39-42.
13. Bhattacharjee, A. et al. 2001. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. PNAS, 98(24):13790-5.
14. Golub, T.R. et al. 1999. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science, 286:531-7.
15. Alizadeh, A.A. et al. 2000. Distinct types of diffuse large B.-cell lymphoma identified by gene expression profiling. Nature, 403:503-11.
16. Bittner, M. et al. 2000. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature, 406:536-40.
17. Perou, C.M. et al. 2000. Molecular portraits of human breast tumours. Nature, 406:747-52.
18. Welsh, J.B. et al. 2001. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. PNAS, 98:1176-81.
19. Alon, U. et al. 1999. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. PNAS, 96:6745-50.
20. Khan, J. et al. 2001. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nature Medicine, 7:673-9.
21. Xi, L. et al. 2005. Prediction of lymph node metastasis by analysis of gene expression profiles in primary lung adenocarcinomas. Clinical Cancer Research, 11:4128-35.
22. Lu, Y. et al. 2006. A gene expression signature predicts survival of patients with stage I non-small cell lung cancer. PLoS Medicine, 3:2229-42.
23. Sun, Z. et al. 2008. Non-overlapping and non-cell type-specific gene expression signatures predict lung cancer survival. Journal of Clinical Oncology, 26:877-83.
24. Jiang, H. et al. 2004. Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes. BMC Bioinformatics, 5:81.
25. Bianchi, F. et al. 2007. Survival prediction of stage I lung adenocarcinomas by expression of 10 genes. The Journal of Clinical Investigation, 117:3436-44.
26. Chen, H. et al. 2007. A five-gene signature and clinical outcome in non-small-cell lung cancer. New England Journal of Medicine, 356:11-20.
27. Lau, S.K. et al. 2007. Three-gene prognostic classifier for early-stage non-small-cell lung cancer. Journal of Clinical Oncology, 25:5562-9.
28. Guo, L. et al. 2006. Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nature Biotechnology, 24(9):1162-9.
29. Patel, S. et al. 2004. caGEDA: a web application for the integrated analysis of global gene expression patterns in cancer. Applied Bioinformatics, 3:49-62.
30. Lyons-Weiler, J. et al. 2004. Tests for finding complex patterns of differential expression in cancers: towards individualized medicine. Bioinformatics, 5:110.
31. Tusher, V.G. et al. 2001. Significance analysis of microarrays applied to the ionizing radiation response. PNAS, 98(9):5116-21.
32. Cover, T.M. et al. 1967. Nearest neighbor pattern classification. IEEE Transactions on Information Theory, 13:21-7.
33. Lyons-Weiler, J. et al. 2005. Assessing the statistical significance of the achieved classification error of classifiers constructed using serum peptide profiles, and a prescription for random sampling repeated studies for massive high-throughput genomic and proteomic studies. Cancer Informatics, 1(1):53-77.
34. Lyons-Weiler, J. et al. 2003. v3 Gene Expression Data Analysis Tool online description and documentation version 1.0. http://bioinformatics2.pitt. edu/GE2/GEDA.html
35. Xi, L. et al. 2005. Prediction of lymph node metastasis by analysis of gene expression profiles in primary lung adenocarcinomas. Clinical Cancer Research, 11(11):4128-35.
36. Tibshirani, R. et al. 2002. Diagnosis of multiple cancer types by shrunken centroids of gene expression. PNAS, 99:6567-72.
37. Choe, S. et al. 2005. Preferred analysis methods for Affymetrix GeneChips revealed by a wholly defined control dataset. Genome Biology, 6:R.16.
38. Ein-Dor, L. et al. 2005. Outcome signature genes in breast cancer: is there a unique set? Bioinformatics, 21(2):171-8.
39. Vapnik, V. 1998. Statistical Learning Theory. New York: Wiley.
40. Breiman, L. et al. 1984. Classification and Regression Trees. Belmont, CA: Wadsworth.
41. Virtanen, C. et al. 2002. Integrated classification of lung tumors and cell lines by expression profiling. PNAS, 99:12357-62.
42. Garber, M.E. et al. 2001. Diversity of gene expression in adenocarcinoma of the lung. PNAS, 98:13784-9.